Emergent BioSolutions

Employees:
1,100
Market Cap:
$1.27 billion
Revenue:
$488.89 million
5 Year Trend:
12.3%
Net Income:
$53.96 million
NYSE:
EBS

Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes. Wikipedia

Emergent BioSolutions
Employees:
1,100
Market Cap:
$1.27 billion
Revenue:
$488.89 million
5 Year Trend:
12.3%
Net Income:
$53.96 million
NYSE:
EBS

Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes. Wikipedia

19

Emergent BioSolutions jobs